Ronald M. Kurtz M.D., President & CEO at RxSight, Inc. (RXST), sold 45,000 shares at $41.09 ($1.8M) on 2023-12-27, disclosed to the SEC on 2023-12-29.
Scheduled sale ($1.8M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.09 | 22,500 | $925K | 50.0% |
| 2 | $41.09 | 22,500 | $925K | 50.0% |
| Total | $41.09 avg | 45,000 | $1.8M | 100% |
| Filing → |
| RXST | SELL | 2024-01-09 | $2.8M | — | Filing → |
| RXST | SELL | 2023-12-18 | $1.6M | — | Filing → |
| RXST | BUY | 2021-08-05 | $2.1M | — | Filing → |